Namaste To Fully Own CannMart Labs, Awaits Processing License

Namaste Technologies Inc. N NXTTF wants to buy the rest of CannMart Labs Inc. that it doesn't currently own. 

The cannabis-focused platform said Thursday it has signed a share purchase agreement to acquire the remaining interest, 49%, in CannMart Labs.

In spring 2018, Namase first obtained a 51% interest in CannMart Labs, an applicant for a processing license under the Cannabis Act for cannabis extraction operations. It's set to financially support the building of its facility in Ontario.

Namaste noted that CannMart Ontario facility is built and ready for BHO extraction and that its application is in the last phase for a processing license.

Under the agreement, Toronto-headquartered company will obtain 49% interest of CannMart Labs from MKD Holdings Inc. and JLLS Holdings Inc. for a purchase price of $4.03 million, with the first part of it or $1.61 million to be paid in Namaste’s shares. The rest should be paid in equal parts in the following nine fiscal quarters, starting on the fiscal quarter that ends February 28, 2021.

Namaste added it is ready to manufacture Cannabis 2.0 products for medical channel customers at CannMart.com and recreational customers via a sister company.

"Acquiring the remaining interest in CannMart Labs is another important milestone achieved in establishing Namaste as a leading company within the Canadian cannabis sector," stated Meni Morim, Chief Executive Officer of Namaste. "CannMart Labs is in the final stage of its application for an important processing licence from Health Canada. It has installed state-of-the-art extraction technology in its facility, which when granted a licence, will be able to produce an array of cannabis products including shatter and live resin, as well as future distillate products such as vape cartridges, gel capsules, tinctures and edibles."

Courtesy image

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisM&ANewsMarketscannabis industrycannabis sales
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
Cannabis Conference Chicago 2024

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.